Cart
sales@molnova.com
SMS1-IN-1
CAS No. 1807943-38-9
SMS1-IN-1 ( —— )
Catalog No. M26452 CAS No. 1807943-38-9
SMS1-IN-1 is a potent inhibitor of sphingomyelin synthase 1 (SMS1, IC50 = 2.1 μM), and can be used in the atherosclerosis studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 147 | Get Quote |
|
| 10MG | 237 | Get Quote |
|
| 25MG | 483 | Get Quote |
|
| 50MG | 698 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1953 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSMS1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMS1-IN-1 is a potent inhibitor of sphingomyelin synthase 1 (SMS1, IC50 = 2.1 μM), and can be used in the atherosclerosis studies.
-
DescriptionSMS1-IN-1 is a potent inhibitor of sphingomyelin synthase 1 (SMS1, IC50 = 2.1 μM), and can be used in the atherosclerosis studies. (In Vitro):SMS1-IN-1 (2.5, 10 and 50?μM) shows inhibitory effect against SMS1 in a dose-dependent manner.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorD2 receptor; D3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1807943-38-9
-
Formula Weight503.4
-
Molecular FormulaC23H23BrN2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESBrc1ccc(CNC(=O)COc2ccc(cc2)S(=O)(=O)NCCc2ccccc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Holmes et al (2010) The identification of a selective DA D2 partial agonist, D3 antagonist displaying high levels of brain exposure. Bioorg.Med.Chem.Lett. 20 2013
molnova catalog
related products
-
Vitexin2''-?O-?p-?co...
Vitexin 2''-O-p-coumarate strongly promotes 2BS cell proliferation induced by H(2)O(2).
-
L-Histidine benzyl e...
L-Histidine benzyl ester bistosylate could play a role in the activation of HutP (an RNA-binding protein) .
-
Homogentisic acid
Homogentisic acid shows interesting antioxidant and antiradical activities, and protective effect against thermal-cholesterol degradation, comparable to those of well known antioxidants.
